Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Nference Raises $60M in Series B Investment Round

Nference Raises $60M in Series B Investment Round

Jan 08, 2020
|
staff reporter

NEW YORK – Nference said Wednesday that it has closed on a $60 million Series B financing round. The bulk of the funding came from Mayo Clinic Ventures, with participation from NTT Venture Capital.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Cost of Meeting Cancellations

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

Genetic Nondiscrimination Act Upheld

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

Enhancement Avoidance

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

PLOS Papers on Shigella Insertion Sequences, Antigens and Plasmodium vivax Diversity, More

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.

What's Popular?

In Business News

  1. Berkeley Lights to Raise up to $153M in IPO

  2. Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia

  3. Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark

  4. FDA Grants EUA for UCSF, Broad Institute, BioSewoom Coronavirus Tests

  5. AbCellera Biologics Files Patent Infringement Suit Against Berkeley Lights

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.